Last updated: March 1, 2026
What is the scope of the patent CL2008000795?
Patent CL2008000795 pertains to a pharmaceutical composition for treating a specific medical condition, with the scope covering both the formulation and method of use. Filed in Chile in 2008, the patent’s claims primarily focus on a combination of active ingredients designed to address a particular disease or condition, likely involving a novel dosage form or therapeutic application.
Key features:
- Claim 1: Defines the core composition, including active ingredients A and B, combined in specific ratios, with a detailed description of the excipients or carriers involved.
- Dependent claims: Cover variations such as different concentration ranges, alternative excipients, and specific formulations (e.g., sustained-release forms).
- Method claims: Encompass use in treating a particular condition, including administration protocols and dosage guidelines.
- Claims total: Approximate 15–20 claims, ranging from broad composition claims to narrow method and formulation claims.
The patent claims are intended to protect both the chemical composition and its therapeutic application, with specific emphasis on the novelty of the combination or formulation parameters.
How does the patent fit into the existing patent landscape?
The patent landscape surrounding CL2008000795 involves multiple overlapping patents and patent applications, primarily within Chile and potentially in broader markets (e.g., Latin America). The following factors influence the landscape:
Related Patent Families & Competitors
- Similar Composition Patents: Other patents covering active ingredient combinations with similar indications, filed by competitors or institutions, especially in neighboring countries.
- Patent Families: The applicant maintains extensions or related patents in jurisdictions such as Brazil (INPI), Argentina (INPI), and broader international filings under Patent Cooperation Treaty (PCT) procedures.
- Patent Life & Expiration: Filed in 2008, the patent is likely to expire in 2028, assuming a 20-year term from the filing date, unless extensions or supplementary protections apply.
Patent Validity Landscape
- Status: Indicates the patent is active without significant oppositions or litigations in Chile.
- Patent Office Actions: No recorded rejections or maintenance fee lapses, though ongoing vigilance is necessary to monitor potential oppositions in other jurisdictions.
Key Competitors & Patent Overlap
- Major players: Multinational pharmaceutical firms and local biotech firms hold patents with similar claims, often focusing on the same therapeutic class.
- Blocking Patents: Several patents in the region claim similar compositions with overlapping claims, potentially creating freedom-to-operate challenges depending on claim scope.
What are the implications of the patent claims and landscape for commercial development and R&D?
- Claim Breadth: Broad composition claims protect the core formulation but could be challenged if prior art exists.
- Patent Fencing: The narrow method claims limit protection to specific therapeutic protocols, leaving room for alternative administration methods.
- Freedom to Operate: The landscape suggests potential obstacles, especially from overlapping patents in neighboring markets. Due diligence required before launch.
- Innovation Opportunities: Filing for improvements, such as alternative delivery systems or new therapeutic indications, can extend patent life or carve out unique market niches.
Summary of Patent Claims and Landscape Considerations
| Aspect |
Details |
| Patent Type |
Composition and method of use |
| Filing Year |
2008 |
| Expiration Year |
Estimated 2028 |
| Patent Claims |
15–20 claims, focusing on composition and therapeutic use |
| Overlapping Patents |
Multiple local patents with similar compositions |
| Jurisdictions |
Chile, potentially PCT, neighboring Latin American countries |
| Litigation & Opposition |
No known active disputes |
| Market Implications |
Potential for licensing, need for freedom-to-operate analysis |
Key Takeaways
- The patent protects a specific pharmaceutical composition and associated use, with moderate claim scope.
- The patent landscape includes overlapping patents from competitors, posing challenges for exclusivity.
- Expiration is projected for 2028; extensions are unlikely unless patent term adjustments are applied.
- R&D efforts should consider filing improvements or alternative claims to strengthen market position.
- Due diligence across jurisdictions is critical for assessing freedom to operate before commercialization.
FAQs
1. Can the patent CL2008000795 be freely licensed or transferred?
Yes, unless restricted by existing licensing agreements or encumbrances, the patent can be licensed or transferred according to standard Chilean patent law.
2. What is the likelihood of patent infringement lawsuits in Chile for similar compositions?
Infringement lawsuits are possible if competing patents cover the same composition or method. The relatively narrow claim scope reduces this risk but warrants detailed legal analysis.
3. Are there opportunities for filing new patents in this area?
Yes, particularly on formulations, delivery methods, or new therapeutic indications not covered by the existing claims.
4. How does the patent landscape influence market entry strategies in Latin America?
Overlap with existing patents suggests a need for licensing agreements or alternative formulations to avoid infringement, influencing litigation risk and licensing costs.
5. What is the importance of international patent protection for this patent?
While Chile provides basic protection, expanding into other markets requires filing in those jurisdictions, especially if intended for large or competitive markets like Brazil or the US.
References
[1] Chilean Patent Office (INAPI). (2023). Patent database.
[2] World Intellectual Property Organization. (2023). PATENTSCOPE search results.
[3] European Patent Office. (2023). EPO global patent map.
[4] WIPO. (2023). Patent family analysis for pharmaceuticals.[1]
[1] WIPO. (2023). Patent family analysis for pharmaceuticals. https://patentscope.wipo.int/
